Pacira Pharmaceuticals, Inc
Clinical trials sponsored by Pacira Pharmaceuticals, Inc, explained in plain language.
-
New shot aims to ease chronic shoulder pain for months
Symptom relief Recruiting nowThis study is testing if a single injection called ZILRETTA can safely reduce pain from shoulder arthritis better than a placebo (saltwater) shot or a standard steroid injection. It will enroll about 150 adults aged 50-80 with moderate shoulder pain. Participants receive one inje…
Phase: PHASE3 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
Freezing nerves to thaw stiff arms: new trial offers hope for spasticity
Symptom relief Recruiting nowThis study is testing whether a device that uses extreme cold to temporarily freeze specific nerves can safely reduce stiffness and tightness in the shoulder and elbow. About 132 adults with arm spasticity from conditions like stroke or spinal cord injury will participate. Some w…
Phase: NA • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
New hope for easing pain in babies and toddlers after major surgery
Symptom relief Recruiting nowThis study aims to see how a long-acting numbing medicine called EXPAREL works in the body and how safe it is for children under 6 years old who are having heart surgery. It will be compared to a standard numbing medicine, bupivacaine. The goal is to find a safe and effective way…
Phase: PHASE1 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Massive 10,000-Person study launches to map the Real-World journey of knee pain
Knowledge-focused Recruiting nowThis study is creating a large registry to collect information on how different pain management treatments work for people with knee osteoarthritis. It will follow 10,000 patients receiving standard care, like injections, nerve blocks, or knee replacement surgery, to track their …
Sponsor: Pacira Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC